Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season

Purpose

This multi-site study assesses the impact of text message reminders on the receipt of COVID-19 and influenza text message reminders takes place primarily in practices from the American Academy of Pediatrics (AAP) Pediatric Research in Office Settings (PROS) network.

Conditions

  • Influenza
  • COVID-19
  • Vaccination Hesitancy

Eligibility

Eligible Ages
Between 6 Months and 17 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Child that: - is 6 months-17 year-old children - due for both a COVID-19 and influenza vaccine - Receives care at study site - Language listed in electronic health record is English or Spanish - Has not opted out of text messages from practice

Exclusion Criteria

  • Has opted out of text messages from practice - Language listed in electronic health record is not English or Spanish

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Health Services Research
Masking
Triple (Care Provider, Investigator, Outcomes Assessor)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Text message influenza and COVID-19 vaccine reminders 		Text message reminders for both influenza and COVID-19 vaccinations
  • Behavioral: Text message influenza and COVID-19 vaccine reminders
    Text message influenza and COVID-19 vaccine reminders
Experimental
Text message influenza vaccine reminders 		Text message reminders only for influenza vaccination
  • Behavioral: Text message influenza vaccine reminders
    Text message influenza vaccine reminders
Experimental
Text message COVID-19 vaccine reminders 		Text message reminders only for COVID-19 vaccination
  • Behavioral: Text message COVID-19 vaccine reminders
    Text message COVID-19 vaccine reminders
No Intervention
Usual Care 		Usual care has no text message

Recruiting Locations

More Details

NCT ID
NCT06603090
Status
Not yet recruiting
Sponsor
Columbia University

Study Contact

Melissa Stockwell, MD MPH
(212) 342-5732
mss2112@cumc.columbia.edu

Detailed Description

The study is to be conducted over the 1st season (September 2024-April 2025) as an effectiveness trial and the 2nd (September 2025-April 2026) as a replication study. This protocol covers the first season. Parents of eligible children who are 6 month-17 year-old who are due for both a COVID-19 and influenza vaccine will be sent text messages. Within each practice site, parents of eligible children will be randomized to receive either: 1) combined COVID-19 and influenza vaccine text message reminders, 2) COVID-19 reminders alone, 3) influenza reminders alone, or 4) no reminders (usual care). Randomization is to be stratified by practice site, age group and prior year's COVID-19/influenza vaccine history. Messages will be sent centrally and managed by the research team.